Osteoporosis Drugs Market Analysis and Forecast Report By Product Type, Formulation, and Region | P&S Intelligence

The osteoporosis drugs market is growing due to the rising geriatric population, increasing incidence of osteoporosis in post-menopausal women, prevalence of osteoporosis in general, and unhealthy lifestyle resulting in poor bone health. The market valued $8,835.4 million in 2015, and Read more ›